ARG Improves Clinical Trial Performance with Vault CTMS

September 12, 2018

Greater visibility, proactive trial management, and better study analytics and reporting are top drivers for clinical operations professionals to improve the use of CTMS. This is a viewpoint shared by Hunter Walker, chief technology officer at ARG.

Please check out the recent Veeva blog post featuring Hunter as he prepares to travel to Philadelphia for their 2018 Summit.

Previous Next

The ARG Approach to Generative AI in Clinical Research

At Atlantic Research Group (ARG), we are excited to explore the possibilities of generative AI (genAI) within clinical research. We […]

April 9, 2025

A Bright Future for ALS Research: Takeaways from the 35th International Symposium on ALS/MND

Last month, Atlantic Research Group sponsored and attended the 35th International Symposium on ALS/MND in Montreal, Canada. Despite the cold […]

January 31, 2025

ARG’s Environment Of Support & Success: 20 Years Of Impact

Making an impact looks different for any business, especially for the variety of Contract Research Organizations (CROs) in the world. […]

May 2, 2024